Summary
As with normal human liver, both focal nodular hyperplasia (FNH) of the liver and a hepatocellular carcinoma were found to contain low levels of high affinity estrogen-binding components. In low-salt sucrose gradients the estrogen binders sedimented at 4S and 8S. Specificity studies indicated a requirement for estrogenic hormones. Progestin-binding studies using labeled and unlabeled ORG 2058 revealed high levels of specific binding in FNH and normal liver cytosol, whereas only insignificant amounts of ORG 2058 binding was found in the hepatocellular carcinoma. As judged by the high apparent dissociation constant (4–14×10−8 mol/l) of the ORG 2058 — binder complex, the apparent lack of 8S binding in low-salt sucrose gradients and the atypical ligand specificity, the progestin receptor nature of these binding entities is unlikely. In contrast, normal liver, FNH, and the hepatocellular carcinoma were found to contain significant quantities of glucocorticoid receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Warren BL, Bellward GD (1979) Benign liver tumors and oral contraceptive therapy: a summary of cases (1972–1978) and a proposed ethiological mechanism. Drug Intell Clin Pharm (Part 1):680–689
Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470–472
Vana J, Murphy GP, Aronoff BL, Baker HW (1977) Primary liver tumors and oral contraceptives: results of a survey. JAMA 238:2154–2158
Christopherson WM, Truman Mays E (1977) Liver tumors and contraceptive steroids: Experience with the first one hundred registry patients. J Natl Cancer Inst 58:167–170
Bojar H, Schütte J, Staib W, Broelsch Ch (1982) Does human liver contain estrogen receptors? A comparative study of estrogen binding in human and rodent liver. Klin Wochenschr 60:417–425
Bojar H, Westerkamp S, Staib W, Broelsch Ch (1980) Identification and partial characterization of glucocorticoid receptors in human liver. Acta Hepatogastroenterol (Stuttg) 27:176–182
Bojar H, Staib W, Beck K, Pilaski J (1980) Investigation on the thermostability of steroid hormone receptors in lyophilized calf uterine tissue powder. Cancer 46:2770–2774
Korenman SG (1968) Radio-ligand binding assay of specific oestrogens using a soluble uterine macromolecule. J Clin Endocrinol Metab 28:127–130
Lowry OH, Rosebrought AL, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Duffy MJ, Duffy GJ (1978) Estradiol receptors in human liver. J Steroid Biochem 9:233–235
Macdonald JS, Lippman ME, Woolley PV, Petrucci PP, Schein PS (1978) Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm. Cancer Chemother Pharmacol 1:135–138
Friedman MA, Demanes DJ, Hoffnam PG (1982) Hepatomas: hormone receptors and therapy. Am J Med 73:362–366
Jänne O, Kontula K, Vihko R (1976) Progestin receptors in human tissues: concentrations and binding kinetics. J Steroid Biochem 7:1066–1068
Philibert D, Raynaud J-P (1974) Binding of progesterone and R5020, a highly potent progestin to human endometrium and myometrium. Contraception 10:457–466
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bojar, H., Petzinna, D., Brölsch, C. et al. Steroid receptor status of focal-nodular hyperplasia of the human liver. Klin Wochenschr 62, 446–450 (1984). https://doi.org/10.1007/BF01726905
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01726905